PACBNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$1.84+0.11 (+6.36%)
Close on Oct 19, 2026
- Market cap
- $571.61M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
Share price
+$0.20 (+12.20%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. grew revenue 2.0% to $159.27M over the twelve months to Jun 30, 2026. Free cash flow was -$123.42M.
Revenue
$159.27M
+2.0% vs. a year earlier
Operating income
-$133.04M
TTM Q2 2026
Free cash flow
-$123.42M
TTM Q2 2026
EPS, diluted
-$0.43
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $571.61M
- P/E ratio
- –
- Price to sales
- 3.59
- Price to book
- –
- Dividend yield
- 0.00%
- Free cash flow yield
- -21.59%
Fundamentals
- Revenue
- $159.27M
- Net income
- -$131.39M
- EPS, diluted
- -$0.43
- Free cash flow
- -$123.42M
- Book value per share
- -$0.11
- Diluted shares
- 311M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$159.27M+2.0% YoY
Gross profit
$57.95M+73.6% YoY
Operating income
-$133.04M
Net income
-$131.39M
EPS, diluted
-$0.43
Free cash flow
-$123.42M
Reported periodTrailing twelve months